A summary of the “Medicina Personalizada y Computación Cuántica: Simulaciones a Medida de tu Genoma” (Oct 2026)
Here's a summary of the “Medicina Personalizada y Computación Cuántica: Simulaciones a Medida de tu Genoma” post from Hive (27 Oct 2026):
Key Takeaways from the Article
What works today (without quantum):
- Classical pharmacogenomics (CYP2D6, CYP2C19, VKORC1 genes for drug metabolism)
- Tumor sequencing for targeted cancer therapies
- Risk panels for immune response, coagulation, drug processing
Current limitations: These are statistical/pattern-based approaches that work well for populations but have variable individual responses. Complex biological interactions are hard to model classically.
How quantum computing could change things:
- Molecular simulation by genome: Quantum computers can natively simulate quantum systems, potentially modeling drug-receptor binding, protein folding, and metabolism for specific genomes with far greater precision than classical computers.
Three concrete research areas (still experimental):
- Oncology precision: Simulating binding energies of cancer drugs against patient-specific protein variants
- Pharmacological metabolism: Perfecting CYP2D6 variant simulations for drugs like codeína
- Rare genetic diseases: Modeling defective proteins with patient-specific variants
Reality check: Not coming to clinics in 2-3 years. Most likely will work "behind the scenes" in drug discovery or for complex cases where classical methods fail. It'll complement (not replace) classical pharmacogenomics.
Key myths clarified:
- ❌ You won't get a quantum-recommended treatment just from genome sequencing yet
- ❌ Quantum won't replace classical methods—it'll be a tool for specific hard cases
- ❌ One quantum processor can't simulate the whole human body—only specific molecular problems
- More to find out in: https://ecency.com/@aljif7/medicina-personalizada-y-computaci-n-cu-ntica-simulaciones-a-med-mvqki10ic00bb8ba?referral=aljif7
That's all folks!
Comentarios